In glioma, activation of TLR4-mediated MyD88-dependent pathway was reported to correlate with upregulation of NF-κB signaling and increased expression of transcription factors (JUN and SRF), implying promoted cellular proliferation [64]. This evidence concerns the gene MYD88 and central nervous system cancer.